Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Grade II-IV Brain Tumors



Status:Recruiting
Conditions:Brain Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:8/29/2018
Start Date:August 23, 2018
End Date:March 31, 2019
Contact:Sarah Prinsloo
Email:sprinsloo@mdanderson.org
Phone:713-745-2668

Use our guide to learn which trials are right for you!

Feasibility of Navigated Repetitive Transcranial Magnetic Stimulation (nrTMS) to Augment the Effects of Motor Rehabilitation in Brain Tumor Patients

This trial studies how well navigated repetitive transcranial magnetic stimulation works in
improving motor rehabilitation in participants with grade II-IV brain tumors. Navigated
repetitive transcranial magnetic stimulation may help improve patients' lost motor function
after surgery.

PRIMARY OBJECTIVES:

I. Determine feasibility of conducting 10 sessions of navigated repetitive transcranial
magnetic stimulation (nrTMS) during the post-surgical rehabilitation time period.

SECONDARY OBJECTIVES:

I. Explore the effects of the nrTMS training program on motor recovery. II. Explore changes
in cortical activity: electroencephalographic (EEG) activity including event-related
potentials (ERPs) and motor evoked potentials (MEPs) will be assessed from baseline to end of
treatment (EOT).

OUTLINE:

Between 1-7 days after standard of care surgery, participants undergo 10 nrTMS sessions over
30 minutes each over 3 weeks.

After completion of study, participants are followed up at 3 months.

Inclusion Criteria:

1. patients with brain tumors associated with the motor cortex

2. understand and read English, sign a written informed consent, and be willing to follow
protocol requirements

3. ECOG Performance Status of 0-2

4. motor impairment must be related to the surgical procedure or the tumor itself (in the
opinion of the treating physician)

5. patients who are within 7 days of brain tumor resection associated with the motor
cortex and who have been enrolled in the study prior to their surgical procedure

Exclusion Criteria:

1. Patients who are taking any antipsychotic medications

2. patients who have ever been diagnosed with bipolar disorder or schizophrenia

3. patients with a history of stroke
We found this trial at
1
site
Houston, Texas 77030
Principal Investigator: Sarah Prinsloo
Phone: 713-745-2668
?
mi
from
Houston, TX
Click here to add this to my saved trials